CLINICAL TRIAL SUMMARY

MDACC Study No:2007-0769 (clinicaltrials.gov NCT No: Not Applicable Clinical Trial)
Title:Assessment of the Impact of Systemic Chemotherapy on the Quality of Life (QOL) in Patients with Metastatic Appendiceal Epithelial Neoplasms (AEN)
Principal Investigator:Cathy Eng
Treatment Agent:None
Study Status:Closed
Study Description:The goal of this research study is to learn if systemic chemotherapy including
5-fluorouracil can help to improve the quality of life in patients with cancer
of the appendix that has spread to the abdomen.

Hide details for General InformationGeneral Information

Disease Group:Advanced Cancers; Gastrointestinal
Phase of Study:N/A
Treatment Agents:None
Treatment Location:Only at MDACC
Estimated Length of Stay in Houston:Patients can be treated on an outpatient basis for this disease.
Supported By:N/A
Return Visit:Following treatment, which can be received at an outside institution if
necessary, study subjects must return to MDACC for follow-up surveillance
visits every 3 months (+/- 1 month) for one year.
Home Care:Systemic chemotherapy given to treat patients while they are enrolled in this
study can be taken either in a hospital on an outpatient basis, either at MDACC
or at another institution, or in the home.


Hide details for Study Contact InformationStudy Contact Information

Physician Name:Cathy Eng
Dept:Gastrointestinal Medical Oncology
For Clinical Trial Enrollment:713-794-1843
For General Questions about Clinical Trials:800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)


Show details for Study Objectives / OutcomesStudy Objectives / Outcomes
Show details for Study Status InformationStudy Status Information
Show details for Enrollment EligibilityEnrollment Eligibility
Show details for Resources and LinksResources and Links
Show details for ResultsResults